Kidney Week 2024

The Mironid team will be in San Diego from 23-27 October attending Kidney Week, an annual scientific conference organised by the American Society of Nephrology.

We look forward to presenting our research, with Catherine (Cass) Kelleher, MD, our Chief Medical Officer, Adele Rowley, our Chief Scientific Officer, and David J P Henderson, our Head of Biology, hosting an abstract presentation titled: Navigating the translation of LoAc® compound efficacy in ADPKD on 24 October from 10am to 12pm PDT as part of the poster session: Cystic Kidney Diseases: Clinical Assessment and Therapeutic Directions [PO1201-1].

We look forward to seeing you there!

Find out more about Kidney Week here: https://lnkd.in/e5X2-HC

The Latest

Mironid Raises Awareness for PKD with 1,000 km Team ChallengeApril 14, 2026

At Mironid, we’re proud to support causes that make a meaningful difference. Last month, our team took part in the Polycystic Kidney Disease (PKD) Charity UK‘s ‘Spring into March’ challenge, raising awareness and supporting the [...]

Q&A with David Henderson, Head of BiologyMarch 19, 2026

ADPKD is a devastating disease that affects more than 12 million people worldwide. Over the past decade, there has been important progress in our understanding of the disease, with meaningful steps forward for both patients and clinicians. However, significant challenges remain. Tolerability [...]

Allosteric modulation of long-form PDE4 enzymes, a novel disease modifying treatment for Autosomal Dominant Polycystic Kidney DiseaseFebruary 18, 2026

Our Chief Scientific Officer, Adele Rowley, will be in London on 18 February for this year’s Ace Drug Discovery Summit, where she will be giving a presentation titled “Allosteric modulation of long-form PDE4 enzymes, a [...]